Romark Laboratories, L.C.
Records under this name other than the patents Romark Laboratories, L.C. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Back to Romark Laboratories, L.C.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,124,632 | Alkylsulfonyl-substituted thiazolide compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,846,727 | Haloalkyl Heteroaryl Benzamide Compounds Lapsed on the fee record Ended Sep 30, 2026 · High confidence | Lapsed on the fee record | Ended Sep 30, 2026 | High confidence |
| US 11,426,388 | Controlled Release Pharmaceutical Formulations of Nitazoxanide Lapsed on the fee record Ended Aug 30, 2026 · Medium confidence | Lapsed on the fee record | Ended Aug 30, 2026 | Medium confidence |
| US 7,645,783 | Halogenated benzamide derivatives Formerly held Term ended Term ended Apr 12, 2026 · From the USPTO record | Term ended | Term ended Apr 12, 2026 | From the USPTO record |
| US 8,633,230 | Viral hepatitis treatment Formerly held Lapsed on the fee record Ended Jan 21, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 21, 2026 | From the USPTO record |
| US 7,285,567 | Halogenated Benzamide Derivatives Formerly held Term ended Term ended Nov 28, 2025 · High confidence | Term ended | Term ended Nov 28, 2025 | High confidence |
| US 9,827,227 | Controlled Release Pharmaceutical Formulations of Nitazoxanide Lapsed on the fee record Ended Nov 28, 2025 · Medium confidence | Lapsed on the fee record | Ended Nov 28, 2025 | Medium confidence |
| US 9,820,975 | Compounds and methods for treating influenza Lapsed on the fee record Ended Nov 21, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 21, 2025 | From the USPTO record |
| US 11,173,149 | Inhibition of protein disulfide-isomerase A3 Lapsed on the fee record Ended Nov 16, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 16, 2025 | From the USPTO record |
| US 7,550,493 | Halogenated benzamide derivatives Formerly held Term ended Term ended Oct 19, 2025 · From the USPTO record | Term ended | Term ended Oct 19, 2025 | From the USPTO record |